These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 28440514

  • 1. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.
    Byun HJ, Darvin P, Kang DY, Sp N, Joung YH, Park JH, Kim SJ, Yang YM.
    Oncol Rep; 2017 Jun; 37(6):3270-3278. PubMed ID: 28440514
    [Abstract] [Full Text] [Related]

  • 2. Salidroside inhibits migration, invasion and angiogenesis of MDA‑MB 231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2.
    Kang DY, Sp N, Kim DH, Joung YH, Lee HG, Park YM, Yang YM.
    Int J Oncol; 2018 Aug; 53(2):877-885. PubMed ID: 29901185
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
    Liang L, Li L, Zeng J, Gao Y, Chen YL, Wang ZQ, Wang XY, Chang LS, He D.
    Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
    [Abstract] [Full Text] [Related]

  • 4. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
    Agarwal C, Tyagi A, Kaur M, Agarwal R.
    Carcinogenesis; 2007 Jul; 28(7):1463-70. PubMed ID: 17341659
    [Abstract] [Full Text] [Related]

  • 5. Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion.
    Si L, Fu J, Liu W, Hayashi T, Nie Y, Mizuno K, Hattori S, Fujisaki H, Onodera S, Ikejima T.
    Mol Cell Biochem; 2020 Jan; 463(1-2):189-201. PubMed ID: 31612353
    [Abstract] [Full Text] [Related]

  • 6. Nitric Oxide-Releasing Drug Glyceryl Trinitrate Targets JAK2/STAT3 Signaling, Migration and Invasion of Triple-Negative Breast Cancer Cells.
    Bouaouiche S, Ghione S, Sghaier R, Burgy O, Racoeur C, Derangère V, Bettaieb A, Plenchette S.
    Int J Mol Sci; 2021 Aug 06; 22(16):. PubMed ID: 34445170
    [Abstract] [Full Text] [Related]

  • 7. Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells.
    Kim S, Jeon M, Lee J, Han J, Oh SJ, Jung T, Nam SJ, Kil WH, Lee JE.
    Oncol Rep; 2014 Nov 06; 32(5):2230-6. PubMed ID: 25175149
    [Abstract] [Full Text] [Related]

  • 8. Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis.
    Chang R, Song L, Xu Y, Wu Y, Dai C, Wang X, Sun X, Hou Y, Li W, Zhan X, Zhan L.
    Nat Commun; 2018 Aug 28; 9(1):3486. PubMed ID: 30154439
    [Abstract] [Full Text] [Related]

  • 9. Genomic regulation of invasion by STAT3 in triple negative breast cancer.
    McDaniel JM, Varley KE, Gertz J, Savic DS, Roberts BS, Bailey SK, Shevde LA, Ramaker RC, Lasseigne BN, Kirby MK, Newberry KM, Partridge EC, Jones AL, Boone B, Levy SE, Oliver PG, Sexton KC, Grizzle WE, Forero A, Buchsbaum DJ, Cooper SJ, Myers RM.
    Oncotarget; 2017 Jan 31; 8(5):8226-8238. PubMed ID: 28030809
    [Abstract] [Full Text] [Related]

  • 10. Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer.
    Dees S, Pontiggia L, Jasmin JF, Mercier I.
    Cancer Biol Ther; 2020 Jun 02; 21(6):506-521. PubMed ID: 32164483
    [Abstract] [Full Text] [Related]

  • 11. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Cheng CC, Shi LH, Wang XJ, Wang SX, Wan XQ, Liu SR, Wang YF, Lu Z, Wang LH, Ding Y.
    Int J Oncol; 2018 Jul 02; 53(1):339-348. PubMed ID: 29750424
    [Abstract] [Full Text] [Related]

  • 12. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N, Bayraktar R, Kahraman N, Mokhlis HA, Calin GA, Lopez-Berestein G, Ozpolat B.
    Breast Cancer Res Treat; 2018 Oct 02; 171(3):593-605. PubMed ID: 29971628
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY, Chang SF, Liao KF, Chiu SC.
    Int J Mol Sci; 2017 Jul 25; 18(8):. PubMed ID: 28757590
    [Abstract] [Full Text] [Related]

  • 16. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K, Son SH, Oh S, Jeon D, Kim H, Noh DY, Kim S, Shin I.
    Oncotarget; 2017 May 30; 8(22):35804-35823. PubMed ID: 28415760
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Eriocalyxin B blocks human SW1116 colon cancer cell proliferation, migration, invasion, cell cycle progression and angiogenesis via the JAK2/STAT3 signaling pathway.
    Lu YM, Chen W, Zhu JS, Chen WX, Chen NW.
    Mol Med Rep; 2016 Mar 30; 13(3):2235-40. PubMed ID: 26795301
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.